Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cellsHe Mi(Roche (Switzerland)), Stephan Gasser(Roche (Switzerland))Journal for ImmunoTherapy of CancerJune 1, 202210.1136/jitc-2021-004268Cited by 18SaveCiteExport RISWatch citationsRelated PapersToll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells|PLoS ONE|2013|79ATM-dependent spontaneous regression of early Eμ-myc–induced murine B-cell leukemia depends on natural killer and T cells|Blood|2013|62